Literature DB >> 10833181

Hepatocellular carcinoma in glycogen storage disease type IV.

R A de Moor1, J J Schweizer, B van Hoek, M Wasser, R Vink, P D Maaswinkel-Mooy.   

Abstract

A 13 year old patient with juvenile type IV glycogen storage disease died of the complications of hepatocellular carcinoma. To our knowledge this is the first reported case of hepatocellular carcinoma in association with type IV glycogen storage disease.

Entities:  

Mesh：

Year:  2000        PMID： 10833181      PMCID： PMC1718356          DOI： 10.1136/adc.82.6.479

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  9 in total

1.  Type IIIb glycogen storage disease associated with end-stage cirrhosis and hepatocellular carcinoma. The Liver Transplant Group.

Authors:  E B Haagsma; G P Smit; K E Niezen-Koning; A S Gouw; L Meerman; M J Slooff
Journal:  Hepatology       Date:  1997-03       Impact factor: 17.425

2.  Liver transplantation for type IV glycogen storage disease.

Authors:  R Selby; T E Starzl; E Yunis; B I Brown; R S Kendall; A Tzakis
Journal:  N Engl J Med       Date:  1991-01-03       Impact factor: 91.245

3.  Glycogenosis type IV: liver transplant at 12 years.

Authors:  A Dhawan; K C Tan; B Portmann; A P Mowat
Journal:  Arch Dis Child       Date:  1994-11       Impact factor: 3.791

4.  Splenic arteriovenous fistula. A rare lesion causing bleeding esophageal varices, ascites, and diarrhea.

Authors:  G Galler; A Yim; J C Emond; E Kirch; D Yousefzadeh; A L Baker
Journal:  Dig Dis Sci       Date:  1996-04       Impact factor: 3.199

5.  Dicarboxylicaciduria and secondary carnitine deficiency in glycogenosis type IV.

Authors:  P D Maaswinkel-Mooy; B J Poorthuis; H H van Gelderen; J J van de Kamp
Journal:  Arch Dis Child       Date:  1987-10       Impact factor: 3.791

6.  99mTc-DTPA activity in the azygos vein before and after sclerotherapy in patients with cirrhosis.

Authors:  K Shimoji; S Itoh; C Kameda; M Shiomi
Journal:  Eur J Radiol       Date:  1993-09       Impact factor: 3.528

7.  Clinical and laboratory findings in four patients with the non-progressive hepatic form of type IV glycogen storage disease.

Authors:  A McConkie-Rosell; C Wilson; D A Piccoli; J Boyle; T DeClue; P Kishnani; J J Shen; A Boney; B Brown; Y T Chen
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

8.  A juvenile variant of glycogenosis IV (Andersen disease).

Authors:  A S Guerra; O P van Diggelen; F Carneiro; R M Tsou; S Simoes; N T Santos
Journal:  Eur J Pediatr       Date:  1986-08       Impact factor: 3.183

9.  Hepatocellular adenoma in glycogen storage disease type IV.

Authors:  N S Alshak; J Cocjin; L Podesta; R van de Velde; L Makowka; P Rosenthal; S A Geller
Journal:  Arch Pathol Lab Med       Date:  1994-01       Impact factor: 5.534
  9 in total
  6 in total

Review 1.  2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations.

Authors:  Ashish Kumar; Subrat K Acharya; Shivaram P Singh; Anil Arora; Radha K Dhiman; Rakesh Aggarwal; Anil C Anand; Prashant Bhangui; Yogesh K Chawla; Siddhartha Datta Gupta; Vinod K Dixit; Ajay Duseja; Naveen Kalra; Premashish Kar; Suyash S Kulkarni; Rakesh Kumar; Manoj Kumar; Ram Madhavan; V G Mohan Prasad; Amar Mukund; Aabha Nagral; Dipanjan Panda; Shashi B Paul; Padaki N Rao; Mohamed Rela; Manoj K Sahu; Vivek A Saraswat; Samir R Shah; Praveen Sharma; Sunil Taneja; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2019-09-23

2.  Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes.

Authors:  Steffen Durinck; Eric W Stawiski; Andrea Pavía-Jiménez; Zora Modrusan; Payal Kapur; Bijay S Jaiswal; Na Zhang; Vanina Toffessi-Tcheuyap; Thong T Nguyen; Kanika Bajaj Pahuja; Ying-Jiun Chen; Sadia Saleem; Subhra Chaudhuri; Sherry Heldens; Marlena Jackson; Samuel Peña-Llopis; Joseph Guillory; Karen Toy; Connie Ha; Corissa J Harris; Eboni Holloman; Haley M Hill; Jeremy Stinson; Celina Sanchez Rivers; Vasantharajan Janakiraman; Weiru Wang; Lisa N Kinch; Nick V Grishin; Peter M Haverty; Bernard Chow; Julian S Gehring; Jens Reeder; Gregoire Pau; Thomas D Wu; Vitaly Margulis; Yair Lotan; Arthur Sagalowsky; Ivan Pedrosa; Frederic J de Sauvage; James Brugarolas; Somasekar Seshagiri
Journal:  Nat Genet       Date:  2014-11-17       Impact factor: 38.330

Review 3.  Insights into the pathogenesis and treatment of cancer from inborn errors of metabolism.

Authors:  Ayelet Erez; Oleg A Shchelochkov; Sharon E Plon; Fernando Scaglia; Brendan Lee
Journal:  Am J Hum Genet       Date:  2011-04-08       Impact factor: 11.025

Review 4.  Liver tumors in children with metabolic disorders.

Authors:  Deborah A Schady; Angshumoy Roy; Milton J Finegold
Journal:  Transl Pediatr       Date:  2015-10

5.  GYS1 or PPP1R3C deficiency rescues murine adult polyglucosan body disease.

Authors:  Erin E Chown; Peixiang Wang; Xiaochu Zhao; Justin J Crowder; Jordan W Strober; Mitchell A Sullivan; Yunlin Xue; Cody S Bennett; Ami M Perri; Bret M Evers; Peter J Roach; Anna A Depaoli-Roach; H Orhan Akman; Bartholomew A Pederson; Berge A Minassian
Journal:  Ann Clin Transl Neurol       Date:  2020-10-09       Impact factor: 4.511

Review 6.  Glycogen storage diseases with liver involvement: a literature review of GSD type 0, IV, VI, IX and XI.

Authors:  Miriam Massese; Francesco Tagliaferri; Carlo Dionisi-Vici; Arianna Maiorana
Journal:  Orphanet J Rare Dis       Date:  2022-06-20       Impact factor: 4.303
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.